JP2005528910A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005528910A5 JP2005528910A5 JP2004511467A JP2004511467A JP2005528910A5 JP 2005528910 A5 JP2005528910 A5 JP 2005528910A5 JP 2004511467 A JP2004511467 A JP 2004511467A JP 2004511467 A JP2004511467 A JP 2004511467A JP 2005528910 A5 JP2005528910 A5 JP 2005528910A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- oligonucleotide
- group
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108091034117 Oligonucleotide Proteins 0.000 claims 23
- 239000002773 nucleotide Substances 0.000 claims 18
- 125000003729 nucleotide group Chemical group 0.000 claims 18
- 108020004707 nucleic acids Proteins 0.000 claims 11
- 150000007523 nucleic acids Chemical class 0.000 claims 11
- 102000039446 nucleic acids Human genes 0.000 claims 11
- 108700042075 T-Cell Receptor Genes Proteins 0.000 claims 8
- 210000001744 T-lymphocyte Anatomy 0.000 claims 8
- 238000000034 method Methods 0.000 claims 7
- 230000000295 complement effect Effects 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 239000000523 sample Substances 0.000 claims 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 4
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims 4
- 239000002751 oligonucleotide probe Substances 0.000 claims 4
- 229960005486 vaccine Drugs 0.000 claims 4
- 108091008874 T cell receptors Proteins 0.000 claims 3
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims 3
- 238000002372 labelling Methods 0.000 claims 3
- 208000023275 Autoimmune disease Diseases 0.000 claims 2
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 claims 2
- 229960002685 biotin Drugs 0.000 claims 2
- 235000020958 biotin Nutrition 0.000 claims 2
- 239000011616 biotin Substances 0.000 claims 2
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 claims 2
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000003752 polymerase chain reaction Methods 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 238000000376 autoradiography Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38628702P | 2002-06-05 | 2002-06-05 | |
| PCT/US2003/017873 WO2003104407A2 (en) | 2002-06-05 | 2003-06-05 | T cell receptor cdr3 sequences and methods for detection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010085593A Division JP2010207226A (ja) | 2002-06-05 | 2010-04-01 | T細胞レセプターcdr3配列および検出のための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005528910A JP2005528910A (ja) | 2005-09-29 |
| JP2005528910A5 true JP2005528910A5 (enExample) | 2006-06-29 |
Family
ID=29736145
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004511467A Withdrawn JP2005528910A (ja) | 2002-06-05 | 2003-06-05 | T細胞レセプターcdr3配列および検出のための方法 |
| JP2010085593A Withdrawn JP2010207226A (ja) | 2002-06-05 | 2010-04-01 | T細胞レセプターcdr3配列および検出のための方法 |
| JP2013042552A Pending JP2013126420A (ja) | 2002-06-05 | 2013-03-05 | T細胞レセプターcdr3配列および検出のための方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010085593A Withdrawn JP2010207226A (ja) | 2002-06-05 | 2010-04-01 | T細胞レセプターcdr3配列および検出のための方法 |
| JP2013042552A Pending JP2013126420A (ja) | 2002-06-05 | 2013-03-05 | T細胞レセプターcdr3配列および検出のための方法 |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1530483B1 (enExample) |
| JP (3) | JP2005528910A (enExample) |
| CN (1) | CN1674931A (enExample) |
| AT (1) | ATE453727T1 (enExample) |
| AU (1) | AU2003237437B2 (enExample) |
| BR (1) | BR0311578A (enExample) |
| CA (1) | CA2485874A1 (enExample) |
| DE (1) | DE60330780D1 (enExample) |
| IL (2) | IL165194A (enExample) |
| MX (1) | MXPA04011646A (enExample) |
| NO (1) | NO20044945L (enExample) |
| NZ (1) | NZ537403A (enExample) |
| PL (1) | PL213315B1 (enExample) |
| RU (1) | RU2004139045A (enExample) |
| WO (1) | WO2003104407A2 (enExample) |
| ZA (1) | ZA200409792B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2018160B1 (en) | 2006-03-16 | 2011-12-14 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
| ES2717469T3 (es) | 2012-08-15 | 2019-06-21 | Tris Pharma Inc | Comprimido masticable de metilfenidato de liberación prolongada |
| US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
| CN108070644B (zh) * | 2016-11-08 | 2021-06-29 | 国家卫生计生委科学技术研究所 | 一种妊娠高血压的诊断系统 |
| AU2018235623A1 (en) * | 2017-03-15 | 2019-08-22 | Hyogo College Of Medicine | Novel biomarkers for cancer immunotherapy |
| US12458592B1 (en) | 2017-09-24 | 2025-11-04 | Tris Pharma, Inc. | Extended release amphetamine tablets |
| US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL97709A (en) * | 1990-03-30 | 2005-05-17 | Brigham & Womens Hospital | Use of an mbp peptide for the preparation of a medicament for the treatment of multiple sclerosis |
| AU774952B2 (en) * | 1999-02-23 | 2004-07-15 | Baylor College Of Medicine | T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection |
-
2003
- 2003-06-05 AT AT03736888T patent/ATE453727T1/de not_active IP Right Cessation
- 2003-06-05 DE DE60330780T patent/DE60330780D1/de not_active Expired - Lifetime
- 2003-06-05 WO PCT/US2003/017873 patent/WO2003104407A2/en not_active Ceased
- 2003-06-05 PL PL374723A patent/PL213315B1/pl unknown
- 2003-06-05 NZ NZ537403A patent/NZ537403A/en not_active IP Right Cessation
- 2003-06-05 CA CA002485874A patent/CA2485874A1/en not_active Abandoned
- 2003-06-05 MX MXPA04011646A patent/MXPA04011646A/es not_active Application Discontinuation
- 2003-06-05 JP JP2004511467A patent/JP2005528910A/ja not_active Withdrawn
- 2003-06-05 EP EP03736888A patent/EP1530483B1/en not_active Expired - Lifetime
- 2003-06-05 AU AU2003237437A patent/AU2003237437B2/en not_active Ceased
- 2003-06-05 CN CNA038186314A patent/CN1674931A/zh active Pending
- 2003-06-05 BR BRPI0311578-0A patent/BR0311578A/pt not_active IP Right Cessation
- 2003-06-05 RU RU2004139045/13A patent/RU2004139045A/ru not_active Application Discontinuation
-
2004
- 2004-11-12 NO NO20044945A patent/NO20044945L/no not_active Application Discontinuation
- 2004-11-14 IL IL165194A patent/IL165194A/en not_active IP Right Cessation
- 2004-12-02 ZA ZA200409792A patent/ZA200409792B/en unknown
-
2010
- 2010-04-01 JP JP2010085593A patent/JP2010207226A/ja not_active Withdrawn
- 2010-06-27 IL IL206650A patent/IL206650A/en not_active IP Right Cessation
-
2013
- 2013-03-05 JP JP2013042552A patent/JP2013126420A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6720144B1 (en) | Detection of clonal T-cell receptor-γ gene rearrangement by PCR/temporal temperature gradient gel electrophoresis (TTGE) | |
| JP2009082137A5 (enExample) | ||
| JP2004528810A5 (enExample) | ||
| JP2011505812A5 (enExample) | ||
| JP2006518186A5 (enExample) | ||
| JPWO2019208671A5 (enExample) | ||
| JP2005537007A5 (enExample) | ||
| JP2019213555A (ja) | ハイブリダイゼーション用バッファー組成物及びハイブリダイゼーション方法 | |
| CA2301301A1 (en) | Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection | |
| JP2009518001A5 (enExample) | ||
| WO2004020662A3 (en) | Method and nucleic acids for the analysis of breast cell proliferative disorders | |
| JP2005528910A5 (enExample) | ||
| Wang et al. | A method for the quantitative analysis of human heat shock gene expression using a multiplex RT-PCR assay | |
| CN114787385A (zh) | 用于检测核酸修饰的方法和系统 | |
| JP5710190B2 (ja) | βアクチン遺伝子のためのプライマーセット、プローブ、アッセイキットおよび検出方法 | |
| Christiano et al. | Compound heterozygosity for nonsense and missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa | |
| FR2639358A1 (fr) | Sondes d'hybridation et procede pour la detection de la presence ou de l'absence d'au moins une sequence variante en un seul test | |
| KR100625325B1 (ko) | 코로나바이러스 검출용 프로브 조성물, 프라이머 혼합물및 이를 이용한 코로나바이러스의 검출방법 | |
| PL1694870T3 (pl) | Primery i sondy do wykrywania genotypów genitalnego HPV | |
| RU2004139045A (ru) | Последовательности cdr3 t-клеточного рецептора и способы детекции | |
| JP4491276B2 (ja) | 標的dna配列において一塩基変異多型の存在を検出する方法及びキット | |
| JP2009268370A (ja) | 標的核酸の検出方法 | |
| KR102115941B1 (ko) | 대사증후군의 위험인자 예측용 단일염기다형성 및 이의 용도 | |
| CN111378735A (zh) | Sma致病基因捕获试剂盒及应用 | |
| KR102039529B1 (ko) | 대사증후군의 위험인자 예측용 단일염기다형성 및 이의 용도 |